Physician profile
Sara Khandan
NPI 1063850808
$23,915.60
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,780 · 2020: $1,841 · 2021: $13K · 2022: $7,182 · 2023: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $10,469.27 | 2019-2021 | |
| Alcon Vision LLC | $6,890.97 | 2019-2022 | |
| Glaukos Corporation | $3,377.38 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $1,266.81 | 2019-2022 | |
| Allergan, INC. | $626.55 | 2019-2022 | |
| Abbvie INC. | $333.71 | 2022 | |
| Bausch & Lomb Americas INC. | $310.09 | 2022-2023 | Envista Mx60 Iol |
| Sun Pharmaceutical Industries INC. | $163.70 | 2020-2021 | |
| New World Medical,INC. | $138.01 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $114.78 | 2020-2021 | |
| Shire North American Group INC | $81.02 | 2019 | |
| Sight Sciences, INC. | $78.03 | 2021 | |
| Horizon Therapeutics Plc | $26.11 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.77 | 2021 | |
| Boston Scientific Corporation | $17.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Khandan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.